Biocytics

Biocytics The Applications of Living Cells. Biotech comoany incubated within Carolina BioOncology Institute. https://www.facebook.com/share/1AvKAi3VJg/?mibextid=wwXIfr

Our mission is to research and develop novel cellular therapies.

🎄 Wishing our partners, collaborators, and scientific community a peaceful holiday season and an exciting start to 2026....
12/27/2025

🎄 Wishing our partners, collaborators, and scientific community a peaceful holiday season and an exciting start to 2026.

🚀 BioCytics 2025: Year in Review
• Progress in autologous cell therapy development
• Expansion of biobank, biospecimen sourcing, and R&D capabilities
• Strengthened collaborations with biotech, academic, and clinical teams
• Continued growth of our technology platform
• FDA INTERACT meeting for BCyIF1 completed
• Celebrated 20-year anniversary

Thank you for supporting our mission to accelerate next-generation cell therapies. Here’s to a groundbreaking new year!

During SITC 2025, our Founder and CEO, Dr. John Powderly, had the opportunity to meet with Dr. Peter Marks, MD, PhD, whe...
12/22/2025

During SITC 2025, our Founder and CEO, Dr. John Powderly, had the opportunity to meet with Dr. Peter Marks, MD, PhD, where they connected over their shared passion for advancing oncology research. It was an honor to discuss the future of immune cell therapies manufactured at the point of care, an area where both BioCytics and Carolina BioOncology Institute remain deeply committed to driving innovation.

We also extend our congratulations to Dr. Marks on receiving the SITC 2025 Innovation Award in recognition of his impactful contributions to the field of immunotherapy.

🌍 In October, our IT team attended EHRCon 2025 in Barcelona, where global experts explored the evolving world of electro...
12/19/2025

🌍 In October, our IT team attended EHRCon 2025 in Barcelona, where global experts explored the evolving world of electronic health records (EHRs), artificial intelligence (AI), and open standards.

John Powderly II, MD, representing Carolina BioOncology Institute and BioCytics, presented how openEHR enables the seamless integration of electronic data capture, laboratory information management systems (LIMS), clinical trial management, and patient EHRs into a unified information ecosystem. This model propels precision medicine forward and lays the foundation for Real-Time Adaptive Clinical Trials, a transformative approach that uses individual patient clinical evidence to continuously improve treatment outcomes for all.

Collaboration, standardization, and innovation remain at the heart of turning clinical data into actionable insights for better patient care.

As we reflect on this year’s meetings and conferences, we’re proud to highlight our August participation at the 2025 Cel...
12/15/2025

As we reflect on this year’s meetings and conferences, we’re proud to highlight our August participation at the 2025 Cell Manufacturing Technologies (CMaT) Summit, a collaborative event designed to connect academic researchers with leaders across the biotech industry.

Our team members Dr. Gaby Lizana-Vasquez and William Paing served as poster judges, reviewing innovative student research and emerging technologies coming out of academic labs. William also contributed as a panelist, offering insight into the current biotech landscape, industry challenges, and the future of cell therapy manufacturing.

We’re excited to continue supporting and mentoring the next generation of biotech innovators. ✨

Have you listened to TIL Talks yet? TIL Talks delivers conversations with leaders and patients shaping the future of cel...
12/11/2025

Have you listened to TIL Talks yet? TIL Talks delivers conversations with leaders and patients shaping the future of cell and gene therapy.

In episode 19 (released October 29), Chris White and Dr. John Powderly return to discuss the rapidly evolving world of digital health in oncology. They unpack challenges with Electronic Health Record systems, the importance of standardized clinical data, and the need to empower patients with access to their own health information. This episode also explores the future of clinical trials, the role of AI, and innovations that will drive earlier cancer detection and improved outcomes.

At BioCytics, we explore how BioDICE technology empowers point-of-care immune cell therapy and next-generation clinical trial design. This episode is a must-listen for anyone passionate about biotech innovation and translational research.

As Breast Cancer Awareness Month comes to a close, we want to highlight that awareness and research must continue every ...
11/21/2025

As Breast Cancer Awareness Month comes to a close, we want to highlight that awareness and research must continue every day of the year. 💗

🔬 Did you know?
• About 30% of early-stage breast cancers may later progress to metastatic disease.
• More than 150,000 people in the U.S. are living with metastatic breast cancer.
• While it is not currently curable, treatment advances are helping patients live longer, fuller lives.

At Carolina BioOncology Institute, we are dedicated to advancing research that brings new hope and options to patients through clinical trials and innovation in cancer care.

Awareness does not end in October, rather it continues with every patient, every day. 💫

Biocytics Inc announces the successful completion of a productive FDA INTERACT meeting supporting our plans to manufactu...
11/21/2025

Biocytics Inc announces the successful completion of a productive FDA INTERACT meeting supporting our plans to manufacture autologous immune cell therapies at the point of care.

This initial regulatory engagement validates the scientific promise of our immuno-oncology platform and our lead investigational fraction, BioCytics Immune Fraction #1 (BCyIF-1). The FDA’s feedback reinforces our continued progress toward an IND submission and first-in-human clinical trials targeted for 2027, advancing our mission to bring innovative cell therapies to patients with solid tumors.

Learn more at www.biocytics.com or read the full announcement at PR Newswire at www.bit.ly/4ibp5of.

Big thank you to the students from Davidson College for visiting! We loved sharing our work, our mission, and the exciti...
11/15/2025

Big thank you to the students from Davidson College for visiting! We loved sharing our work, our mission, and the exciting career paths ahead in biotech and in immuno-oncology cancer research.


Today we welcomed to BioCytics Inc for an exciting presentation on Revolutionizing Immune Cell Therapy with Functional ...
11/12/2025

Today we welcomed to BioCytics Inc for an exciting presentation on Revolutionizing Immune Cell Therapy with Functional Single Cell Analysis.

We continue to explore advanced technologies that accelerate discovery and deepen our understanding of immune cell function to strengthen our cell therapy development pipeline.

We are proud to celebrate Dr. Gaby Lizana-Vasquez, BioCytics HAL Research Scientist, for being selected as a 2025 Intern...
11/07/2025

We are proud to celebrate Dr. Gaby Lizana-Vasquez, BioCytics HAL Research Scientist, for being selected as a 2025 International Society for Cell & Gene Therapy Cell Therapy Leadership Training Program Scholar. 🧬

This recognition reflects our mission at BioCytics to advance cell therapies through innovation, collaboration, and scientific excellence.

We are honored to see Dr. Lizana-Vasquez representing our team among the next generation of leaders shaping the future of cellular medicine. 🌍

Biocytics and Carolina BioOncology Institute are proud to sponsor the Biomedical Sciences Symposium hosted by UNC Charlo...
09/15/2025

Biocytics and Carolina BioOncology Institute are proud to sponsor the Biomedical Sciences Symposium hosted by UNC Charlotte’s Center for Biomedical Engineering and Science in collaboration with the North Carolina Biotechnology Center.

This event unites breakthrough discoveries, translational research, and new collaborations in biomedical sciences. We are honored to support a forum that further advances science, fosters partnerships, and shapes the future of biomedical research!🔬

09/07/2025

✨ Congratulations to Dr. John Powderly and the entire team at Carolina BioOncology Institute on 20 years of advancing cancer care and research! ✨

Founded by Dr. John Powderly in 2005, CBOI began with a vision to provide patients with access to the latest Phase I immuno-oncology clinical trials. From humble beginnings of decision making around a kitchen table, the institute has grown into a nationally recognized center offering cutting-edge treatments for late-stage cancer patients.

Over the past two decades, CBOI has opened more than 150 early-phase immunotherapy trials and has become a beacon of hope for patients seeking innovative treatment options.

Here's to 20 years of dedication, innovation, and compassionate care and to many more! 👏💙

Address

9801 Kincey Avenue, Suite 145
Huntersville, NC
28078

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 12pm

Website

Alerts

Be the first to know and let us send you an email when Biocytics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Biocytics:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram